Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

First-in-human results for three investigational inhibitors show anti-tumor activity without unmanageable effects on blood glucose.

Dr. Michael Koehler, Medical Director at Affinity Whole Health, offers tips ahead of the holiday season. VALLEY VIEW, OH / ACCESSWIRE / December 13, 2024 / As we approach the 2024 holiday season, a ...

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk of ...

An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced br ...

With several of these drugs going off patent in the next few years, OneSource is poised to see big growth in the generic ...

A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in early breast cancer.

The Biden administration has called for Medicare and Medicaid to expand coverage of weight-loss drugs for people struggling ...

"Most days, I avoid setting an alarm clock and let my body wake up naturally with the sunlight. The sun is filled with Yang ...